A tuberculosis (TB) vaccine candidate was safe and immunogenic but not efficacious in infants, researchers reported.
In a randomized trial of 2,797 infants, the vaccine candidate was well-tolerated compared with a placebo injection and induced "modest" cell-mediated immune responses, according to Helen McShane, MD, of the University of Oxford, and colleagues.
Read the full story: http://bit.ly/WY81Eh
Source: Medpage Today
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
ViiV Healthcare is developing a self-injectable HIV drug similar to Cabenuva; HHS met with insurance companies to resolve COVID-19 vaccine coverage issues; the FDA has greenlit drugmaker Novo Nordisk to add reports of ileus, or intestinal blockage, to its Ozempic label.
Read More
2 Clarke Drive
Cranbury, NJ 08512